PS
IONS icon

Portfolio Solutions’s Ionis Pharmaceuticals IONS Stock Holding History

Portfolio Solutions’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,000
Closed -$44K – 103
2018
Q1 		$44K Hold
1,000
– – 0.01% 76
2017
Q4 		$50K Hold
1,000
– – 0.01% 70
2017
Q3 		$51K Hold
1,000
– – 0.01% 71
2017
Q2 		$51K Hold
1,000
– – 0.01% 69
2017
Q1 		$40K Buy
+1,000
New +$44.9K 0.01% 68

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Portfolio Solutions's IONS Position: Q2 2018 in Review

Portfolio Solutions sold out of Ionis Pharmaceuticals (IONS) in Q2 2018, closing a stake of 1,000 shares — an estimated $44K sold.

Portfolio Solutions first reported a position in IONS in Q1 2017 and held it in 5 quarters. The position peaked at $51K in Q3 2017. 307 funds tracked by Wall St. Rank hold IONS as of Q2 2018.

  • Portfolio Solutions reported no remaining Ionis Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Portfolio Solutions sold 1,000 Ionis Pharmaceuticals shares in Q2 2018, an estimated $44K.
  • Portfolio Solutions first reported a position in Ionis Pharmaceuticals in Q1 2017 and held it in 5 quarters.
  • Portfolio Solutions's Ionis Pharmaceuticals position peaked at $51K in Q3 2017.
  • 307 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2018.

Based on Portfolio Solutions's 13F filing for Q2 2018, filed 13 Jul 2018.